🏥 VAERS Vaccine Data Browser

🔒 Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

📖 Help & Search Guide

Column Icons Legend

💀 Death
🏥 Hospitalized
🚑 Emergency Room
♿ Disability
⚠️ Life Threatening

How to Search

💡 Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "📥 Export CSV" to download filtered data (max 10,000 records)

💡 Frequently Asked Questions (FAQ)

What is this site?

🏥 VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • ✅ Early warning system for potential safety signals
  • ✅ Open and transparent - publicly accessible
  • ✅ Accepts all reports regardless of likelihood of causation
  • ✅ Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • ⚠️ Reports are unverified - not investigated before publication
  • ⚠️ Cannot determine if vaccine caused the event
  • ⚠️ Underreporting - not all adverse events are reported
  • ⚠️ Overreporting - coincidental events may be reported
  • ⚠️ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

⚠️ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
🔄 Reset 📥 Export CSV
ID Age Sex State Date ▼ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative 💀 🏥 🚑 ♿ ⚠️
2846563 F MS 06/19/2025 HPV9
HPV9
 MERCK & CO. INC.
MERCK & CO. INC.
 Y018389
Inappropriate schedule of product administration, No adverse event; Inappropriat... Inappropriate schedule of product administration, No adverse event; Inappropriate schedule of product administration, No adverse event More
Caller stated patient did not report any symptoms.; patient who is currently 19 years old received t... Caller stated patient did not report any symptoms.; patient who is currently 19 years old received their 1st dose of GARDASIL 9 in 2018 and their 2nd dose on 3/27/2025.; This spontaneous report was received from a pharmacist and refers to a 19-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. In 2018, the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (lot #, expiration date, dose, frequency, route of administration and anatomical location of vaccine were not reported); on 27-MAR-2025, the patient received the second dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), lot #Y018389, expiration date was not reported, but upon internal validation was established as 04-NOV-2026 (dose, route of administration and anatomical location of vaccine were not reported) (inappropriate schedule of drug administration); both doses were administrated for Prophylaxis. The reporter stated that the patient experienced Caller stated patient did not report any symptoms (No adverse event). More
2846564 VA 06/19/2025 DTPPVHBHPB
RVX
 MSP VACCINE COMPANY
UNKNOWN MANUFACTURER

No adverse event, Product storage error; No adverse event, Product storage error No adverse event, Product storage error; No adverse event, Product storage error
No additional AE; HCP called to report inadvertent administration of ROTATEQ and VAXELIS after a tem... No additional AE; HCP called to report inadvertent administration of ROTATEQ and VAXELIS after a temperature excursion that occurred on 07MAY2025. ROTATEQ and VAXELIS were administered to a patient on 21MAY2025. Limited demographics provided. HCP originally called on; This spontaneous report was received from a Nurse Practitioner and refers to a 6-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 07-May-2025, Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, Inactivated Poliovirus (VAXELIS), dose number 1, (lot # and expiration date were not reported), and Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ), dose number 1, (lot # and expiration date were not reported) had a temperature excursion of 1.4 degrees Celsius for 18 minutes and was administered to the patient on 21-May-2025 (Product storage error). No adverse event was reported.; Reporter's Comments: More
2846565 PA 06/19/2025 MMRV
 MERCK & CO. INC.
 Y006771
No adverse event, Product storage error No adverse event, Product storage error
no adverse event; one dose of PROQUAD with temperature excursion was inadvertently administered; Thi... no adverse event; one dose of PROQUAD with temperature excursion was inadvertently administered; This spontaneous report was received from an office manager and refers to a identified patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient was inadvertently administered a 0.5 mL dose of improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y006771, expiration date: 24-Sep-2025) for prophylaxis. The administered dose of the vaccine experienced several temperature excursions as follows: On 09-AUG-2024: -10�C up to 8�C (-9.3C) for 1 hours, 53 minutes; on 29-SEP-2024: -14�C up to -10�C (-13.6C) for 30 minutes; on 16-JUN-2025: -14�C up to -10�C (-14.4C) for 9 minutes. The patient did not experienced any adverse event. This is one of two reports received from the same source.; Reporter's Comments: Keywords : MUL More
2846566 06/19/2025 VARZOS
 UNKNOWN MANUFACTURER
 UNK
Atrial fibrillation, Cardiac operation, Immediate post-injection reaction Atrial fibrillation, Cardiac operation, Immediate post-injection reaction
This vaccine sent into immediate afib; This serious case was reported by a consumer via interactive ... This vaccine sent into immediate afib; This serious case was reported by a consumer via interactive digital media and described the occurrence of atrial fibrillation in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced atrial fibrillation (Verbatim: This vaccine sent into immediate afib) (serious criteria GSK medically significant and clinically significant/intervention required). The outcome of the atrial fibrillation was not resolved. It was unknown if the reporter considered the atrial fibrillation to be related to Shingles vaccine. The company considered the atrial fibrillation to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 10-JUN-2025 This case was reported by a patient via interactive digital media. The patient said that the Shingles vaccine sent him/her into immediate afib (atrial fibrillation). The patient had no previous heart problems. The patient had to have two surgeries on his/her heart. The patient was still taking heart medications. The patient stated did not get vaccine. If get a rash go immediately to the physician.; Sender's Comments: Atrial fibrillation is an unlisted event which is considered unrelated to GSK vaccine Shingles vaccine More
2846567 F 06/19/2025 VARZOS
 UNKNOWN MANUFACTURER
 UNK
Headache, Inflammation Headache, Inflammation
Inflammed arm, general inflammation; Headache; This non-serious case was reported by a consumer and ... Inflammed arm, general inflammation; Headache; This non-serious case was reported by a consumer and described the occurrence of inflammation in a 51-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (12 years ago), chickenpox (had chickenpox as a child), asthma and hashimoto's disease. Previously administered products included Shingles vaccine (Received 1st dose of Shingles vaccine in March, with no issues.). Concurrent medical conditions included hypothyroidism and seasonal allergy. Concomitant products included levothyroxine. On 05-JUN-2025, the patient received the 2nd dose of Shingles vaccine. On 05-JUN-2025, less than a day after receiving Shingles vaccine, the patient experienced inflammation (Verbatim: Inflammed arm, general inflammation) and headache (Verbatim: Headache). The patient was treated with ibuprofen (Advil). The outcome of the inflammation and headache were not resolved. It was unknown if the reporter considered the inflammation and headache to be related to Shingles vaccine. It was unknown if the company considered the inflammation and headache to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 09-JUN-2025 The patient had inflammed arm, general inflammation and headache. The first vaccine did not have any reaction like this. The patient had been using ice packs and advil for 4 days to help ease the reaction. More
2846568 F 06/19/2025 MENB
 NOVARTIS VACCINES AND DIAGNOSTICS
 UNK
Pain in extremity Pain in extremity
arm pain; This non-serious case was reported by a consumer via sales rep and described the occurrenc... arm pain; This non-serious case was reported by a consumer via sales rep and described the occurrence of pain in arm in a 18-year-old female patient who received Men B NVS (Bexsero) for prophylaxis. On 16-MAY-2025, the patient received Bexsero (left arm). On 16-MAY-2025, less than a day after receiving Bexsero, the patient experienced pain in arm (Verbatim: arm pain). The outcome of the pain in arm was resolved. The reporter considered the pain in arm to be related to Bexsero. It was unknown if the reporter considered the pain in arm to be related to Bexsero Pre-Filled Syringe Device. The company considered the pain in arm to be related to Bexsero. It was unknown if the company considered the pain in arm to be related to Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-JUN-2025 The patient experienced expected arm pain after dose. More
2846569 70 M NJ 06/19/2025 COVID19
VARZOS
VARZOS
 UNKNOWN MANUFACTURER
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 UNK
UNK
UNK
Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure; Herpes z... Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure More
Suspected vaccination failure / Lack of drug effect; shingles on the side of his stomach-a few small... Suspected vaccination failure / Lack of drug effect; shingles on the side of his stomach-a few small red spots / Lack of drug effect; This serious case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis and COVID-19 vaccine for prophylaxis. The patient's past medical history included epstein-barr viremia (Epstein Barre and elevated levels of virus in system, diagnosed when he was child). On 18-JAN-2022, the patient received the 2nd dose of Shingrix. On 11-OCT-2021, the patient received the 1st dose of Shingrix. On 18-OCT-2021, the patient received COVID-19 vaccine. On an unknown date, more than 2 years after receiving Shingrix and Shingrix and not applicable after receiving COVID-19 vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure / Lack of drug effect) (serious criteria GSK medically significant) and shingles (Verbatim: shingles on the side of his stomach-a few small red spots / Lack of drug effect). The patient was treated with valaciclovir hydrochloride (Valtrex). The outcome of the vaccination failure and shingles were not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix. It was unknown if the reporter considered the shingles to be related to COVID-19 vaccine. The company considered the vaccination failure to be unrelated to Shingrix and Shingrix. It was unknown if the company considered the shingles to be related to Shingrix, Shingrix and COVID-19 vaccine. Additional Information: GSK Receipt Date: 10-JUN-2025 The patient self-reported this case for himself. The patient had completed the series for Shingrix with 2 doses. About 7 to 10 days ago in 2025, he was diagnosed with shingles on the side of his stomach (a few small red spots or lack of effect). This diagnosis was made by a dermatologist. The patient was prescribed Valtrex (unknown if generic or brand dispensed, strength not disclosed) to be taken twice daily for 5 days. The patient stated that he was vaccinated with a COVID booster (unknown manufacturer). In 2025, more than 2 years after received COVID-19 vaccine, the patient experienced shingles. This case was considered as suspected vaccination failure as details regarding laboratory confirmation regarding shingles were unknown at the time of reporting. No further information was obtained or provided.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (concomitant COVID-19 vaccine, h/o epstein-barr viremia and insufficient information provided about laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingrix (Dose 1 and Dose 2). More
2846570 M 06/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Fatigue, Headache, Inappropriate schedule of product administration Fatigue, Headache, Inappropriate schedule of product administration
fatigue; headache; drug dose administration interval too long; This non-serious case was reported b... fatigue; headache; drug dose administration interval too long; This non-serious case was reported by a consumer via call center representative and described the occurrence of fatigue in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix with an associated reaction of fatigue (received first dose on 23 or 24 October 2024). On 11-JUN-2025, the patient received the 2nd dose of Shingrix (right arm). On 11-JUN-2025, less than a day after receiving Shingrix, the patient experienced fatigue (Verbatim: fatigue), headache (Verbatim: headache) and drug dose administration interval too long (Verbatim: drug dose administration interval too long). Rechallenge with Shingrix was positive. The outcome of the fatigue and headache were not resolved and the outcome of the drug dose administration interval too long was not applicable. It was unknown if the reporter considered the fatigue and headache to be related to Shingrix. It was unknown if the company considered the fatigue and headache to be related to Shingrix. Additional Information: GSK Receipt Date: 12-JUN-2025 Patient received his second dose on 11 JUN 2025. Patient had the same reaction with both dose one and dose 2. Patient had fatigue and a headache, these symptoms after the second dose have been persisting for two days. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccinations schedule. More
2846571 F 06/19/2025 VARZOS
VARZOS
 UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
 UNK
UNK
Allodynia, Herpes zoster, Pain, Scar, Urinary tract infection; Vaccination failu... Allodynia, Herpes zoster, Pain, Scar, Urinary tract infection; Vaccination failure More
Urinary tract infection; Shingles; scars; shooting pain; terrible surface pain that a slight touch; ... Urinary tract infection; Shingles; scars; shooting pain; terrible surface pain that a slight touch; Suspected Vaccination failure; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a 75-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected Vaccination failure) (serious criteria GSK medically significant), urinary tract infection (Verbatim: Urinary tract infection) (serious criteria hospitalization), shingles (Verbatim: Shingles), scar (Verbatim: scars), shooting pain (Verbatim: shooting pain) and allodynia (Verbatim: terrible surface pain that a slight touch). The outcome of the vaccination failure, urinary tract infection, shingles and scar were not reported and the outcome of the shooting pain and allodynia were not resolved. It was unknown if the reporter considered the vaccination failure, urinary tract infection, shingles, scar, shooting pain and allodynia to be related to Shingles vaccine. The company considered the vaccination failure and urinary tract infection to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles, scar, shooting pain and allodynia to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 07-JUN-2025 The patient had the vaccines, and still had shingles, on top of a major urinary tract infection that put in the hospital a year and a half ago at the age of 75. On top of scars, the patient was continued to have terrible surface pain that a slight touch, even by her bra, sends shooting pain through her. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine. Urinary tract infection is an unlisted event which is considered unrelated to GSK Shingles vaccine. More
✓
2846572 06/19/2025 VARZOS
 UNKNOWN MANUFACTURER
 UNK
Malaise Malaise
very sick; This non-serious case was reported by a consumer via interactive digital media and descri... very sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Concomitant products included VARICELLA ZOSTER VACCINE. On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: very sick). The outcome of the sickness was not reported. It was unknown if the reporter considered the sickness to be related to Shingles vaccine. It was unknown if the company considered the sickness to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 09-JUN-2025 This case was reported by a patient via interactive digital media. The patient's family members who got the 2 shot vaccine and got very sick. More
2846573 06/19/2025 VARZOS
 UNKNOWN MANUFACTURER
 UNK
Pain Pain
they hurt but you will get over it; This non-serious case was reported by a consumer via interactive... they hurt but you will get over it; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: they hurt but you will get over it). The outcome of the pain was not reported. It was unknown if the reporter considered the pain to be related to Shingles vaccine. It was unknown if the company considered the pain to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 12-JUN-2025 This case was reported by a patient via interactive digital media. The patient reported that he/she took first shingles shots they hurt but will get over it having shingles is horrible it was worth taking the shots. More
2846574 F PA 06/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Fatigue, Pain in extremity Fatigue, Pain in extremity
tiredness; arm soreness; This non-serious case was reported by a consumer via call center representa... tiredness; arm soreness; This non-serious case was reported by a consumer via call center representative and described the occurrence of tiredness in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included herpes simplex type ii (About 20 years ago, the patient contacted genital herpes). Concomitant products included aciclovir sodium (Acyclovir) and valaciclovir hydrochloride (Valtrex). On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced tiredness (Verbatim: tiredness) and pain in arm (Verbatim: arm soreness). The outcome of the tiredness and pain in arm were unknown. It was unknown if the reporter considered the tiredness and pain in arm to be related to Shingrix. It was unknown if the company considered the tiredness and pain in arm to be related to Shingrix. Linked case(s) involving the same patient: US2025AMR071843, US2025AMR076294 Additional Information: GSK Receipt Date: 09-JUN-2025 The reporter was the patient. The patient also lives part of the year in another country. The patient received the first of Shingrix in 2018 The only side effects experienced by the patient from any dose of Shingrix were arm soreness and tiredness. About 20 years ago, the patient contacted genital herpes (Herpes Simplex 2). The patient had taken Valtrex, then went to Acyclovir for suppressive therapy. For tolerance to second dose, refer case US2025AMR076294 For tolerance to third dose, refer case US2025AMR071843; Sender's Comments: US-GSK-US2025AMR071843:Same patient, 3rd dose US-GSK-US2025AMR076294:Same patient, 2nd dose More
2846575 F PA 06/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Fatigue, Pain in extremity Fatigue, Pain in extremity
tiredness; arm soreness; This non-serious case was reported by a consumer via call center representa... tiredness; arm soreness; This non-serious case was reported by a consumer via call center representative and described the occurrence of tiredness in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix with an associated reaction of fatigue (received first dose in 2018, refer case US2025AMR076267). Concurrent medical conditions included herpes simplex (contacted genital herpes). Concomitant products included aciclovir sodium (Acyclovir) and valaciclovir hydrochloride (Valtrex). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced tiredness (Verbatim: tiredness) and pain in arm (Verbatim: arm soreness). Rechallenge with Shingrix was positive. The outcome of the tiredness and pain in arm were unknown. It was unknown if the reporter considered the tiredness and pain in arm to be related to Shingrix. It was unknown if the company considered the tiredness and pain in arm to be related to Shingrix. Linked case(s) involving the same patient: US2025AMR071843, US2025AMR076267 Additional Information: GSK Receipt Date: 09-JUN-2025 The reporter was the patient. The patient also lives part of the year in another country. The patient received the second dose of Shingrix in 2018 The only side effects experienced by the patient from any dose of Shingrix were arm soreness and tiredness. About 20 years ago, the patient contacted genital herpes (Herpes Simplex 2). The patient had taken Valtrex, then went to Acyclovir for suppressive therapy. For tolerance to third dose, refer case US2025AMR071843; Sender's Comments: US-GSK-US2025AMR076267:Same patient, 1st dose US-GSK-US2025AMR071843:Same patient, 3rd dose More
2846576 NY 06/19/2025 HEPA
 GLAXOSMITHKLINE BIOLOGICALS
 55M72
Expired product administered Expired product administered
the administration of an expired dose of Havrix; This non-serious case was reported by a other healt... the administration of an expired dose of Havrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received HAV (Havrix) (batch number 55M72, expiry date 13-DEC-2024) for prophylaxis. On an unknown date, the patient received Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: the administration of an expired dose of Havrix). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 12-JUN-2025 An administrative assistant from a healthcare center was called to report the administration of an expired dose of Havrix, which led to an expired vaccine used. She mentioned not having further information about patient data nor date of administration nor dose number. She stated that more information could be known after talking with her manager. The vaccine administration facility was the same as primary reporter. More
2846577 11 F TX 06/19/2025 MNQ
 NOVARTIS VACCINES AND DIAGNOSTICS
 AMVB044A
Product preparation issue Product preparation issue
maladministration of the diluent only; maladministration of the diluent only; This non-serious case ... maladministration of the diluent only; maladministration of the diluent only; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB044A, expiry date 31-JUL-2025) for prophylaxis. On 12-JUN-2025, the patient received Menveo. On 12-JUN-2025, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: maladministration of the diluent only) and inappropriate dose of vaccine administered (Verbatim: maladministration of the diluent only). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 13-JUN-2025 The Vaccine Administration Facility was the same as Primary Reporter A Medical Technician called to report about the maladministration of the diluent only of Menveo vaccine to a patient yesterday which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The Medical Technician wanted guidance if they have to revaccinate the patient. More
2846578 71 F NJ 06/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 PJ353
Erythema, Injected limb mobility decreased, Injection site pain Erythema, Injected limb mobility decreased, Injection site pain
Patient received her first dose of shingrix on Monday 6/16/25. She called the pharmacy on Wednesday ... Patient received her first dose of shingrix on Monday 6/16/25. She called the pharmacy on Wednesday 6/18 stating she had pain at site and throughout arm and had trouble lifting it the first two days after getting it. She also had 2 areas of redness. By Wednesday, she could lift her arm but was still experiencing a great deal of pain. She took some tylenol which helped. Advised to continue tylenol, ice the area, and take an antihistamine. More
2846579 89 M IA 06/19/2025 COVID19
 MODERNA
 3032233
Death Death
Passed away Passed away
✓
2846580 0.5 M WI 06/19/2025 DTAPHEPBIP
DTAPHEPBIP
DTAPHEPBIP
PNC20
PNC20
PNC20
UNK
UNK
UNK
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
PFIZER\WYETH
PFIZER\WYETH
PFIZER\WYETH
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
 Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Crying, Decreased eye contact, Depressed level of consciousness, Developmental r... Crying, Decreased eye contact, Depressed level of consciousness, Developmental regression, Food refusal; Gastrooesophageal reflux disease, Infant irritability, Poor feeding infant, Pyrexia, Screaming; Vomiting; Crying, Decreased eye contact, Depressed level of consciousness, Developmental regression, Food refusal; Gastrooesophageal reflux disease, Infant irritability, Poor feeding infant, Pyrexia, Screaming; Vomiting; Crying, Decreased eye contact, Depressed level of consciousness, Developmental regression, Food refusal; Gastrooesophageal reflux disease, Infant irritability, Poor feeding infant, Pyrexia, Screaming; Vomiting More
Relfux/vomit, no longer eating solids, no longer breastfeeding, no longer babbling, eye contact avoi... Relfux/vomit, no longer eating solids, no longer breastfeeding, no longer babbling, eye contact avoidance, moments of being unalert, fever, fussiness, screaming, crying More
✓
2846581 14 F KS 06/19/2025 MENB
 NOVARTIS VACCINES AND DIAGNOSTICS
 49M9N
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
Patient given Bexsero at 14 years old and was not at an increased risk or met special situations to ... Patient given Bexsero at 14 years old and was not at an increased risk or met special situations to receive early. Dad informed of side effects of vaccine, but did not state patient had any symptoms when talking to physician over phone. More
2846582 70 M 06/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 mg5s9
Extra dose administered Extra dose administered
Received a 3rd dose of shingrix Received a 3rd dose of shingrix
2846583 71 M 06/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 mg5s9
Extra dose administered Extra dose administered
Received 3rd dose of vaccine Received 3rd dose of vaccine
2846584 16 M AR 06/19/2025 HPV9
HPV9
MENB
MENB
 MERCK & CO. INC.
MERCK & CO. INC.
NOVARTIS VACCINES AND DIAGNOSTICS
NOVARTIS VACCINES AND DIAGNOSTICS
 1957407
1957407
25DB5
25DB5
Chromaturia, Glucose urine absent, Nitrite urine absent, Protein urine absent, S... Chromaturia, Glucose urine absent, Nitrite urine absent, Protein urine absent, Specific gravity urine normal; Urinary occult blood negative, Urobilinogen urine decreased, White blood cells urine negative, pH urine normal; Chromaturia, Glucose urine absent, Nitrite urine absent, Protein urine absent, Specific gravity urine normal; Urinary occult blood negative, Urobilinogen urine decreased, White blood cells urine negative, pH urine normal More
Patient began having very dark urine less than 24 hours after vaccination. No change with increase i... Patient began having very dark urine less than 24 hours after vaccination. No change with increase in fluids for three days. More
2846585 18 F MA 06/19/2025 MENB
MENB
 PFIZER\WYETH
PFIZER\WYETH
 HP9989
HP9989
Abdominal pain upper, Dizziness, Dyspnoea, Electrocardiogram, Fatigue; Feeling h... Abdominal pain upper, Dizziness, Dyspnoea, Electrocardiogram, Fatigue; Feeling hot, Heart rate increased, Nausea More
Timeline reported by patient: 2 pm felt fatigue and dizzy 4 pm stomachache/ pain, nausea 8 pm stomac... Timeline reported by patient: 2 pm felt fatigue and dizzy 4 pm stomachache/ pain, nausea 8 pm stomachache pain stopped, face hot, trouble breathing 9 pm fast heartbeat, trouble breathing, attempted albuterol with no effect 10 pm ER: cannot confirm it was vaccine Confirmed no injection site swelling, itchiness, only slightly soreness Treatment at ER: Given Prednisone and Diphenhydramine Discharged with: EPINEPHrine 0.3 mg/0.3 mL injection, Loratadine 10 mg tablet, PredniSONE 50 MG tablet More
2846586 69 F 06/19/2025 PNC21
 MERCK & CO. INC.
 Z002626
Erythema, Peripheral swelling, Pruritus Erythema, Peripheral swelling, Pruritus
Patient said she started to experience redness, swelling, and itchiness in the arm in which she rece... Patient said she started to experience redness, swelling, and itchiness in the arm in which she received the vaccination, later in the day after receiving the vaccine. She reported to the pharmacy 5 days later to discuss. She said her symptoms were starting to improve. Pharmacist discussed mitigation measures for what appeared to be a local injection site reaction. More
2846587 11 M MA 06/19/2025 MNQ
MNQ
TDAP
TDAP
 SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
 U8494AA
U8494AA
3CA30C1
3CA30C1
Fall, Haematemesis, Head injury, Headache, Mass; Pallor, Palpitations, Syncope; ... Fall, Haematemesis, Head injury, Headache, Mass; Pallor, Palpitations, Syncope; Fall, Haematemesis, Head injury, Headache, Mass; Pallor, Palpitations, Syncope More
Pt arriving to office at approx 9am. Pt received vaccines at approx 930am, <5 minutes later synca... Pt arriving to office at approx 9am. Pt received vaccines at approx 930am, <5 minutes later syncable episode resulting in pt falling backwards and hitting head. C/o of headache, small bump to back of head, vomiting x1. + PERRLA, VSS, pale in color, pt reports feeling like "heart is racing" AP-84. Advised to go to ED, mom declining states will go home and monitor pt for 1 hr and then determine if feels ED is appropriate. Concussion protocol reviewed w/ mom and states understanding. Pt leaving office, accompanied by parent, at approx 1040am. More
2846588 50 F OH 06/19/2025 PNC20
 PFIZER\WYETH
 MF0425
Immediate post-injection reaction, Injected limb mobility decreased, Injection s... Immediate post-injection reaction, Injected limb mobility decreased, Injection site pain, Limb discomfort, Sleep disorder More
Immediately upon injection I felt a lot of pain in and around injection site which was upper left sh... Immediately upon injection I felt a lot of pain in and around injection site which was upper left shoulder (6/13/25). Upon returning home my left arm started to feel heavy and very sore from the shoulder down. I messaged the doctor to let her know via MyChart and she told me to go to the ED if symptoms worsened. I put ice on my shoulder and tried to rest it elevated. I also took ibuprofen. I had to physically lift my arm up to get it to move. The pain continued throughout the night and I was not able to sleep on my side due to the pain. The next day (06/14/25) the pain continued from the shoulder down my arm. I tried ice, ibuprofen, and rest again. It didn't really get worse, just didn't get any better. Same thing about not being able to sleep on my side that evening. On 06/15/25-06/17/25, I thought it felt slightly better, but I still needed to lift my arm up at times. On the evening of 06/17/25 I tried sleeping on my left side again but when I awoke the pain began again and lasted through the day on 6/18/25. I messaged the doctor again about the pain, but didn't get a response. After a restless sleep on 6/18/25 I awoke on 6/19/25 (the day I am writing this report) and made an appointment with the doctor because I was in a lot of pain throughout my left shoulder and arm. I also messaged her again explaining why I scheduled the appointment, but asked if there was any other ideas of what to do. She messaged me back and offered to send a referral to Orthopedic Surgery, which I accepted. More
2846589 1.75 F MT 06/19/2025 DTAPIPV
 SANOFI PASTEUR
 U8209CB
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
This is a 21 month old who received a QUADRACEL vaccination. QUADRACEL is NOT licensed for below 4 y... This is a 21 month old who received a QUADRACEL vaccination. QUADRACEL is NOT licensed for below 4 years old. The child did not have any potential side effects or display any untoward symptoms. Spoke with Sanofi vaccine rep and she stated, "per CDC the Quadracel vaccine inadvertently administered to a child under 4 years of age, the dose may be counted as valid for the DTAP and/or IPV series and does NOT need to be repeated". More
2846590 1.67 M MO 06/19/2025 HEPA
 MERCK & CO. INC.
 Y014585
Rash Rash
Rash appearing on arms, chest, abdomen, thighs, and legs, with some spots on his back. Rash appearing on arms, chest, abdomen, thighs, and legs, with some spots on his back.
2846591 64 M SC 06/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
Pruritus, Swelling face Pruritus, Swelling face
facial swelling and hand itching 18 hours post dose administration facial swelling and hand itching 18 hours post dose administration
2846592 0.17 M FL 06/19/2025 DTAPIPVHIB
PNC20
RV5
 SANOFI PASTEUR
PFIZER\WYETH
MERCK & CO. INC.
 UK224AC
MF0415
Y014318
Mechanical urticaria, Rash erythematous; Mechanical urticaria, Rash erythematous... Mechanical urticaria, Rash erythematous; Mechanical urticaria, Rash erythematous; Mechanical urticaria, Rash erythematous More
rash 24 hours after vaccination, red rash that coalesce in pressure zones and it is evanescent. pers... rash 24 hours after vaccination, red rash that coalesce in pressure zones and it is evanescent. persistent , dermographism positive. More
2846593 5 M NY 06/19/2025 DTAPIPV
MMRV
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 YNZX2
Z006Z78
Febrile convulsion; Febrile convulsion Febrile convulsion; Febrile convulsion
febrile seizure lasting about 1-2 minutes febrile seizure lasting about 1-2 minutes
2846594 1 F CA 06/19/2025 HEPA
MMR
PNC15
VARCEL
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
 42DM9
Y018963
Y017360
Z003767
Febrile convulsion, Pyrexia; Febrile convulsion, Pyrexia; Febrile convulsion, Py... Febrile convulsion, Pyrexia; Febrile convulsion, Pyrexia; Febrile convulsion, Pyrexia; Febrile convulsion, Pyrexia More
Patient received vaccines on 5/30/25 around 10:30am. Per parents, who are both physicians, patient d... Patient received vaccines on 5/30/25 around 10:30am. Per parents, who are both physicians, patient developed a fever on 5/31/25, temperature unknown. Parents gave Tylenol and Motrin as needed. That same night while patient was sleeping, the patient experienced what parents describe as a febrile seizure, which lasted under 2 minutes long. Patient is currently stable, at baseline, with no deficits. More
2846595 68 M ME 06/19/2025 COVID19
 PFIZER\BIONTECH
Condition aggravated, Migraine Condition aggravated, Migraine
Approximately 6 weeks after receiving the second Pfizer COVID19 injection, my migraine began to be d... Approximately 6 weeks after receiving the second Pfizer COVID19 injection, my migraine began to be daily. I have suffered migraines since my teen years but since the vaccine, this new pattern emerged. The pain comes on mid-morning to mid-afternoon every day almost without fail. I have not experienced a completely migraine-free day since the vaccine. More
2846596 55 F OH 06/19/2025 HEP
 MERCK & CO. INC.
 9K34M
Asthenia, Blood glucose normal, Dizziness, Electrocardiogram normal Asthenia, Blood glucose normal, Dizziness, Electrocardiogram normal
Upon patient checking out pt began to feel dizzy and became weak, vitals wnl, EKG and Accucheck perf... Upon patient checking out pt began to feel dizzy and became weak, vitals wnl, EKG and Accucheck performed, also wnl, patient sent to the emergency room by EMS More
2846597 13 M MA 06/19/2025 TYP
YF
 SANOFI PASTEUR
SANOFI PASTEUR
 Y2A021M
UK137AA
Incorrect route of product administration, No adverse event; Incorrect route of ... Incorrect route of product administration, No adverse event; Incorrect route of product administration, No adverse event More
No adverse event reported. YF-Vax given by IM route instead of subcutaneous. No adverse event reported. YF-Vax given by IM route instead of subcutaneous.
2846598 12 F GA 06/19/2025 HPV9
MNQ
TDAP
 MERCK & CO. INC.
NOVARTIS VACCINES AND DIAGNOSTICS
GLAXOSMITHKLINE BIOLOGICALS
 Y018398
57h54
235D2
Haemorrhage, Lip injury, Suture insertion, Syncope; Haemorrhage, Lip injury, Sut... Haemorrhage, Lip injury, Suture insertion, Syncope; Haemorrhage, Lip injury, Suture insertion, Syncope; Haemorrhage, Lip injury, Suture insertion, Syncope More
After receiving her three vaccines patient had a syncopal event. Patient was seated and soon after t... After receiving her three vaccines patient had a syncopal event. Patient was seated and soon after the last vaccine she fell forward and to the floor. According to the father patient hit her face and suffered a cut to her lower lip(on the right side). Medical assistant was in the room with parents and soon after likely under 30 seconds, I (MD) was in the room. Patient was in on the floor and soon after recovered after her syncopal event. Likely lasted under 20 sec. She had small amount of bleeding at the site of injury. Patient was observed and did well in office but was upset. Due to her laceration she was sent to the Peds ER for stitches. Pt did well per ER notes and received 4 stitches. More
2846599 11 F IN 06/19/2025 MENB
 NOVARTIS VACCINES AND DIAGNOSTICS
 7MN4C
No adverse event, Wrong product administered No adverse event, Wrong product administered
NO adverse effects, child given wrong vaccine NO adverse effects, child given wrong vaccine
2846600 1.25 M MA 06/19/2025 DTAPIPVHIB
HEPA
 SANOFI PASTEUR
MERCK & CO. INC.
 UK167AA
Y018582
No adverse event, Wrong product administered; No adverse event, Wrong product ad... No adverse event, Wrong product administered; No adverse event, Wrong product administered More
The normal procedure is to mix the HIB powder with the DTaP-IPV liquid prior to administration of th... The normal procedure is to mix the HIB powder with the DTaP-IPV liquid prior to administration of the vaccine. Instead, the HIB powder was mixed with a sterile diluent meant for other vaccines. No Adverse Reactions Occured. More
2846601 16 M 06/19/2025 MNP
 PFIZER\WYETH
 LJ0077
Chest discomfort, Fatigue, Pain in extremity, Pyrexia Chest discomfort, Fatigue, Pain in extremity, Pyrexia
FEVER, FATIGUE , CHEST DISCOMFORT , arm pain started at the evening of the vaccination. Today 06/19/... FEVER, FATIGUE , CHEST DISCOMFORT , arm pain started at the evening of the vaccination. Today 06/19/25 mother states that the child is doing better . afebrile since last evening More
2846602 17 F NC 06/19/2025 MNQ
TYP
 SANOFI PASTEUR
SANOFI PASTEUR
 u8256ab
x1a261
Extra dose administered, No adverse event; Extra dose administered, No adverse e... Extra dose administered, No adverse event; Extra dose administered, No adverse event More
Menquadfi ACWY administered to patient in error. This 2 dose series was already completed. Patient w... Menquadfi ACWY administered to patient in error. This 2 dose series was already completed. Patient was due for a different type of Menigitis vaccine. RN obtained and administered wrong vaccine resulting in patient receiving 3rd Menquadfi ACWY vaccine. Mother, who was present in health department with patient and patient were notified immediately after administration error was noted. No adverse reactons noted. More
2846603 37 F CA 06/19/2025 VARCEL
VARCEL
 MERCK & CO. INC.
MERCK & CO. INC.
 Y015108
Y015108
Injection site inflammation, Injection site pruritus, Injection site swelling, I... Injection site inflammation, Injection site pruritus, Injection site swelling, Injection site vesicles, Injection site warmth; Rash More
pt experienced vaccine associated rash as a side effect of the vaccine. the pt explained she was ex... pt experienced vaccine associated rash as a side effect of the vaccine. the pt explained she was experiencing itchiness of the site, it felt hot to touch, and it was getting larger in terms of being inflamed. when examining the site of the reaction, we saw it was swollen and had some signs of blistering. More
2846604 1 F MI 06/19/2025 MMR
VARCEL
 MERCK & CO. INC.
MERCK & CO. INC.
 Y020517
Y019318
Diarrhoea, Pyrexia, Rash, Rash erythematous, Rash vesicular; Diarrhoea, Pyrexia,... Diarrhoea, Pyrexia, Rash, Rash erythematous, Rash vesicular; Diarrhoea, Pyrexia, Rash, Rash erythematous, Rash vesicular More
MMR (# 2 - got one early due to international travel), Varicella vaccines given on 6/12. One day pri... MMR (# 2 - got one early due to international travel), Varicella vaccines given on 6/12. One day prior patient had rhinorrhea, for one day following the vaccine she had diarrhea. Starting 6/17 she developed fever 101-103 improved with iburprofen. At the same time vesicular rash developed on her right hand and since spread to all extremities, trunk, back, and gluteal region. Vesicular, erythematous, umbilicated, varicella- like. It's itchy. Office visit 6/19 and we prescribed zyrtec 2.5mg BID PRN, expectant and symptomatic management at this time. Plan for follow up Monday 6/23 if rash/fever persists. More
2846605 69 F OH 06/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 93N4J
Injection site erythema, Injection site mass, Injection site rash, Injection sit... Injection site erythema, Injection site mass, Injection site rash, Injection site warmth More
The patient had a golf ball size knot at the place of injection, with redness/rash at the site and w... The patient had a golf ball size knot at the place of injection, with redness/rash at the site and was hot to the touch. Told the patient she might be experiencing an allergic reaction and she went to the doctor and get doxycycline and prednisone. More
2846606 76 F IA 06/19/2025 COVID19
 MODERNA
 8080803
Expired product administered, No adverse event Expired product administered, No adverse event
Patient was administered an expired vaccine. Vaccine expired on 06/11/2025, vaccine given on 06/18/2... Patient was administered an expired vaccine. Vaccine expired on 06/11/2025, vaccine given on 06/18/2025. Patient didn't experience any adverse events. More
2846607 16 F NC 06/19/2025 MENB
MNQ
 NOVARTIS VACCINES AND DIAGNOSTICS
NOVARTIS VACCINES AND DIAGNOSTICS
 7MN4C
57H54
Musculoskeletal stiffness, Vomiting; Musculoskeletal stiffness, Vomiting Musculoskeletal stiffness, Vomiting; Musculoskeletal stiffness, Vomiting
When patient in the car after the vaccines given in clinic, patient parent states that patient had a... When patient in the car after the vaccines given in clinic, patient parent states that patient had a seizure. Her "legs and arms went stiff". Mom gave rescue seizure medication nasally in the car. Patient did have one episode of emesis in the parking lot. Parent states that she would like to take child home, give her rescue medications and allow her to rest. Advised emergency room if more seizure activity progresses. Continuing to monitor currently with follow up calls. More
2846608 47 F IA 06/19/2025 PNC21
PNC21
 MERCK & CO. INC.
MERCK & CO. INC.
 z004302
z004302
Chest discomfort, Hypoaesthesia oral, Injection site erythema, Loss of personal ... Chest discomfort, Hypoaesthesia oral, Injection site erythema, Loss of personal independence in daily activities, Pain in extremity; Paraesthesia, Paraesthesia oral More
tingling sensation starting 06/18/2025 in left side of face that moved to mouth/lips then moved to... tingling sensation starting 06/18/2025 in left side of face that moved to mouth/lips then moved to tongue leading to no sensation in mouth about 30 minutes after vaccine administration that continued throughout the night. on 06/19/2025 redness at the injection site was noted, tingling in tongue, intense pain in left arm. chest tightness that disrupts activities above normal activities of daily living. Patient was given 20ml oral Benadryl in clinic and sent home. More
2846609 50 F MN 06/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 MG5S9
Erythema, Fatigue, Skin ulcer, Skin warm, Swelling Erythema, Fatigue, Skin ulcer, Skin warm, Swelling
Warmth, redness, swelling, fatigue, skin ulceration, reported via my chart on 6/13/25. Patient was a... Warmth, redness, swelling, fatigue, skin ulceration, reported via my chart on 6/13/25. Patient was advised to use warm compress, Tylenol, and ibuprofen. If worsens or does not improve needs to be seen. Patient was seen in clinic for further evaluation7 days after receiving vaccine. Physican recommended OTC Hydrocortisone cream and saw improvements to the skin ulceration. More
2846610 39 M CO 06/19/2025 MMR
 GLAXOSMITHKLINE BIOLOGICALS
 GE974
Contraindicated product administered, No adverse event Contraindicated product administered, No adverse event
Patient stated that his doctor told him to get the MMR vaccine. Patient came to the clinic to receiv... Patient stated that his doctor told him to get the MMR vaccine. Patient came to the clinic to receive MMR. I gave him the vaccine, but did not realize that the patient was prescribed and taking skyrizi. He came back to the clinic today (6/19/2025) to receive his second dose of the MMR vaccine. He was sent away since he is still taking the skyrizi. He did state that he did not experience any side effect or adverse reactions after receiving the first dose. More
2846611 60 F NM 06/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 3273h
Erythema, Skin warm, Swelling Erythema, Skin warm, Swelling
Slight redness, swelling and warmth. ADvised Ibuprofen and benydryl Slight redness, swelling and warmth. ADvised Ibuprofen and benydryl
2846612 90 F GA 06/19/2025 PNC21
 MERCK & CO. INC.
 y013009
Erythema, Peripheral swelling, Pruritus, Skin warm Erythema, Peripheral swelling, Pruritus, Skin warm
patient came in and showed pharmacist her arm which was very red to her elbow, hot to touch and itch... patient came in and showed pharmacist her arm which was very red to her elbow, hot to touch and itchy. She said it swelled up on Monday after she got and the red was even larger earlier in the week. She had taken benadryl for it . Pharmacist suggested seeing a doctor. More
📋 Privacy Policy & Data Disclaimer